NASDAQ:PMD - Psychemedics Stock Price, Price Target & More

$21.30 +0.25 (+1.19 %)
(As of 04/25/2018 12:06 PM ET)
Previous Close$20.65
Today's Range$21.15 - $21.50
52-Week Range$15.99 - $27.99
Volume6,325 shs
Average Volume13,094 shs
Market Capitalization$113.41 million
P/E Ratio22.94
Dividend Yield2.91%
Beta0.73

About Psychemedics (NASDAQ:PMD)

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company's tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a longer period of time. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, and opiates, including heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine. The company offers its services to employers for applicant and employee testing; treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use; and Fortune 500 companies and small to mid-size corporations. Psychemedics Corporation was founded in 1985 and is headquartered in Acton, Massachusetts.

Receive PMD News and Ratings via Email

Sign-up to receive the latest news and ratings for PMD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:PMD
CUSIPN/A
Phone978-206-8220

Debt

Debt-to-Equity Ratio0.13%
Current Ratio3.28%
Quick Ratio3.28%

Price-To-Earnings

Trailing P/E Ratio22.94
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$39.70 million
Price / Sales2.95
Cash Flow$1.5627 per share
Price / Cash13.63
Book Value$3.39 per share
Price / Book6.28

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$6.12 million
Net Margins15.42%
Return on Equity29.23%
Return on Assets19.83%

Miscellaneous

Employees231
Outstanding Shares5,490,000

How to Become a New Pot Stock Millionaire

Psychemedics (NASDAQ:PMD) Frequently Asked Questions

What is Psychemedics' stock symbol?

Psychemedics trades on the NASDAQ under the ticker symbol "PMD."

How often does Psychemedics pay dividends? What is the dividend yield for Psychemedics?

Psychemedics announced a quarterly dividend on Wednesday, March 7th. Stockholders of record on Monday, March 19th will be given a dividend of $0.15 per share on Thursday, March 29th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 2.82%. The ex-dividend date is Friday, March 16th. View Psychemedics' Dividend History.

How were Psychemedics' earnings last quarter?

Psychemedics Co. (NASDAQ:PMD) issued its earnings results on Wednesday, March, 7th. The company reported $0.22 earnings per share for the quarter. The firm had revenue of $9.76 million for the quarter. Psychemedics had a net margin of 15.42% and a return on equity of 29.23%. View Psychemedics' Earnings History.

When is Psychemedics' next earnings date?

Psychemedics is scheduled to release their next quarterly earnings announcement on Wednesday, August, 1st 2018. View Earnings Estimates for Psychemedics.

Who are some of Psychemedics' key competitors?

Who are Psychemedics' key executives?

Psychemedics' management team includes the folowing people:
  • Mr. Raymond C. Kubacki Jr., Chairman, Chief Exec. Officer and Pres (Age 73)
  • Mr. James V. Dyke, Corp. VP of Sales & Marketing (Age 53)
  • Dr. Michael I. Schaffer Ph.D., VP of Laboratory Operations (Age 73)
  • Dr. Werner A. Baumgartner Ph.D., Founder
  • Ms. Annette Baumgartner, Founder

Has Psychemedics been receiving favorable news coverage?

News stories about PMD stock have trended somewhat positive on Wednesday, according to Accern Sentiment. The research group scores the sentiment of news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Psychemedics earned a daily sentiment score of 0.01 on Accern's scale. They also assigned headlines about the company an impact score of 45.02 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

How do I buy shares of Psychemedics?

Shares of PMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Psychemedics' stock price today?

One share of PMD stock can currently be purchased for approximately $21.30.

How big of a company is Psychemedics?

Psychemedics has a market capitalization of $113.41 million and generates $39.70 million in revenue each year. Psychemedics employs 231 workers across the globe.

How can I contact Psychemedics?

Psychemedics' mailing address is 289 GREAT ROAD, ACTON MA, 01720. The company can be reached via phone at 978-206-8220.


MarketBeat Community Rating for Psychemedics (PMD)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  65 (Vote Outperform)
Underperform Votes:  42 (Vote Underperform)
Total Votes:  107
MarketBeat's community ratings are surveys of what our community members think about Psychemedics and other stocks. Vote "Outperform" if you believe PMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PMD will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Psychemedics (NASDAQ:PMD) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/25/2016 forward)

Earnings

Psychemedics (NASDAQ:PMD) Earnings History and Estimates Chart

Earnings by Quarter for Psychemedics (NASDAQ:PMD)

Psychemedics (NASDAQ PMD) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/1/2018        
4/24/2018Q1 2018$0.23$10.94 millionViewN/AView Earnings Details
3/7/2018Q4 2017$0.22$9.76 millionViewN/AView Earnings Details
10/24/2017Q3 2017$0.25$10.05 millionViewN/AView Earnings Details
8/2/2017Q2 2017$0.16$9.68 millionViewN/AView Earnings Details
4/25/2017Q1 2017$0.27$10.21 millionViewN/AView Earnings Details
2/6/2017Q4 2016$0.43$10.76 millionViewN/AView Earnings Details
10/26/2016Q3 2016$0.49$11.85 millionViewN/AView Earnings Details
7/26/2016Q2 2016$0.30$9.70 millionViewN/AView Earnings Details
2/10/2016Q4 2015$0.03$6.13 millionViewN/AView Earnings Details
10/28/2015Q3 2015$0.15$7.08 millionViewN/AView Earnings Details
7/28/2015Q2 2015$0.05$7.00 millionViewN/AView Earnings Details
4/27/2015Q1 2015$0.05$6.76 millionViewN/AView Earnings Details
2/10/2015Q414$0.08$0.13$6.80 millionViewN/AView Earnings Details
10/30/2014Q3 2014$0.17$7.70 millionViewN/AView Earnings Details
7/28/2014$0.03$0.16$7.69 millionViewN/AView Earnings Details
4/29/2014Q114$0.12$0.14$6.40 million$7.00 millionViewN/AView Earnings Details
2/10/2014Q4$0.16$6.48 millionViewN/AView Earnings Details
10/28/2013Q313$0.20$7.06 millionViewN/AView Earnings Details
8/5/2013Q2 2013$0.20$6.90 millionViewN/AView Earnings Details
5/7/2013Q1 2013$0.16$6.43 millionViewN/AView Earnings Details
2/25/2013Q4 2012$0.05$5.55 million$5.66 millionViewN/AView Earnings Details
11/5/2012Q3 2012$0.17ViewN/AView Earnings Details
8/7/2012Q2 2012$0.19ViewN/AView Earnings Details
5/8/2012Q1 2012$0.16ViewN/AView Earnings Details
2/23/2012Q4 2011$0.08ViewN/AView Earnings Details
11/3/2011Q3 2011$0.19$0.21ViewN/AView Earnings Details
8/10/2011Q2 2011$0.21ViewN/AView Earnings Details
5/5/2011Q1 2011$0.10$0.16ViewN/AView Earnings Details
3/2/2011Q4 2010$0.08ViewN/AView Earnings Details
11/4/2010Q3 2010$0.12$0.16ViewN/AView Earnings Details
8/10/2010Q2 2010$0.10$0.17ViewN/AView Earnings Details
5/11/2010Q1 2010$0.06$0.10ViewN/AView Earnings Details
2/23/2010Q4 2009$0.10ViewN/AView Earnings Details
11/3/2009Q3 2009$0.15ViewN/AView Earnings Details
8/4/2009Q2 2009$0.03ViewN/AView Earnings Details
5/7/2009Q1 2009$0.01ViewN/AView Earnings Details
2/18/2009Q4 2008$0.03ViewN/AView Earnings Details
11/3/2008Q3 2008$0.17ViewN/AView Earnings Details
7/28/2008Q2 2008$0.20ViewN/AView Earnings Details
4/30/2008Q1 2008$0.17ViewN/AView Earnings Details
2/14/2008Q4 2007$0.17ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Psychemedics (NASDAQ:PMD) Dividend Information

Psychemedics pays an annual dividend of $0.60 per share, with a dividend yield of 2.82%. PMD's most recent quarterly dividend payment was Thursday, March 29.
Most Recent Dividend:3/29/2018
Annual Dividend:$0.60
Dividend Yield:2.82%
Payout Ratio:N/A
Dividend Payments by Quarter for Psychemedics (NASDAQ:PMD)

Psychemedics (NASDAQ:PMD) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/7/2018Quarterly$0.153/16/20183/19/20183/29/2018
10/25/2017quarterly$0.153.48%11/3/201711/6/201711/17/2017
8/3/2017quarterly$0.152.82%8/10/20178/14/20178/24/2017
4/26/2017quarterly$0.153.08%5/4/20175/8/20175/18/2017
2/6/2017Quarterly$0.152.89%2/14/20172/16/20172/27/2017
10/27/2016quarterly$0.152.62%11/3/201611/7/201611/17/2016
7/27/2016quarterly$0.153.29%8/3/20168/5/20168/15/2016
4/27/2016quarterly$0.154.15%5/4/20165/6/20165/18/2016
2/11/2016quarterly$0.155.75%2/18/20162/22/20163/4/2016
10/29/2015quarterly$0.156.01%11/5/201511/9/201511/19/2015
7/29/2015quarterly$0.155.12%8/5/20158/7/20158/18/2015
4/28/2015quarterly$0.153.71%5/6/20155/8/20155/18/2015
2/11/2015quarterly$0.153.97%2/19/20152/23/20153/6/2015
10/30/2014quarterly$0.154.17%11/6/201411/10/201411/20/2014
10/30/2014quarterly$0.1511/20/201411/10/2014
7/29/2014quarterly$0.154.22%8/5/20148/7/20148/18/2014
4/29/2014quarterly$0.153.81%5/7/20145/9/20145/19/2014
2/10/2014quarterly$0.153.8%2/19/20142/21/20143/7/2014
10/28/2013quarterly$0.154.28%11/6/201311/11/201311/22/2013
8/5/2013quarterly$0.154.68%8/13/20138/15/20138/28/2013
5/7/2013quarterly$0.155.34%5/15/20135/17/20135/30/2013
2/25/2013quarterly$0.154.98%3/5/20133/7/20133/21/2013
(Data available from 1/1/2013 forward)

Insider Trades

Psychemedics (NASDAQ PMD) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 9.90%
Institutional Ownership Percentage: 55.53%
Insider Trading History for Psychemedics (NASDAQ:PMD)
Institutional Ownership by Quarter for Psychemedics (NASDAQ:PMD)

Psychemedics (NASDAQ PMD) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/14/2017Raymond C Kubacki JrCEOBuy1,000$16.88$16,880.00178,228View SEC Filing  
9/6/2017Michael I SchafferVPSell7,548$20.41$154,054.6841,273View SEC Filing  
9/5/2017Michael I SchafferVPSell4,400$20.37$89,628.0041,273View SEC Filing  
9/1/2017Michael I SchafferVPSell981$21.16$20,757.9641,273View SEC Filing  
3/9/2017James V DykeVPSell10,513$20.56$216,147.2817,050View SEC Filing  
12/14/2016James V DykeVPSell5,091$22.83$116,227.5331,024View SEC Filing  
12/9/2016Fred J WeinertDirectorSell4,601$24.45$112,494.4526,983View SEC Filing  
11/18/2016Neil LernerVPSell3,000$24.75$74,250.0025,722View SEC Filing  
11/15/2016James V DykeVPSell10,000$23.56$235,600.0037,654View SEC Filing  
3/2/2016Harry F Sr Connick SrDirectorBuy700$12.83$8,981.0041,362View SEC Filing  
2/26/2016Harry F Sr Connick SrDirectorBuy1,000$12.63$12,630.0040,262View SEC Filing  
2/24/2016Harry F Sr Connick SrDirectorBuy2,000$12.36$24,720.0038,262View SEC Filing  
2/22/2016Harry F Sr Connick SrDirectorBuy1,000$12.61$12,610.0038,262View SEC Filing  
2/19/2016Harry F Sr Connick SrDirectorBuy1,000$11.95$11,950.0037,662View SEC Filing  
2/16/2016Michael I SchafferVPBuy4,507$11.09$49,982.6346,472View SEC Filing  
12/2/2015David HodgeDirectorBuy550,000$0.01$5,500.00
11/24/2015David HodgeDirectorBuy260,000$0.01$2,600.00
9/14/2015Raymond C. Kubacki, Jr.CEOBuy2,000$10.12$20,240.00185,647View SEC Filing  
9/10/2015Neil LernerVPBuy3,000$10.32$30,960.0030,051View SEC Filing  
6/16/2015Michael I SchafferVPSell2,837$14.62$41,476.94View SEC Filing  
4/8/2015David HodgeDirectorBuy3,000$0.01$30.00
(Data available from 1/1/2013 forward)

Headlines

Psychemedics (NASDAQ PMD) News Headlines

Source:
DateHeadline
Psychemedics: 1Q Earnings SnapshotPsychemedics: 1Q Earnings Snapshot
finance.yahoo.com - April 25 at 10:21 AM
Psychemedics Announces 1Q Record Revenues and Dividend Increase of 20%Psychemedics Announces 1Q Record Revenues and Dividend Increase of 20%
finance.yahoo.com - April 25 at 10:21 AM
Psychemedics (PMD) Scheduled to Post Quarterly Earnings on MondayPsychemedics (PMD) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - April 16 at 3:46 AM
Only 3 Days Left To Cash In On Psychemedics Corporation (NASDAQ:PMD) Dividend, Is It Worth Buying?Only 3 Days Left To Cash In On Psychemedics Corporation (NASDAQ:PMD) Dividend, Is It Worth Buying?
finance.yahoo.com - March 12 at 9:46 AM
Psychemedics Corp. Plans Quarterly Dividend of $0.15 (PMD)Psychemedics Corp. Plans Quarterly Dividend of $0.15 (PMD)
www.americanbankingnews.com - March 11 at 7:52 AM
BRIEF-Psychemedics Corporation Q4 Earnings Per Share $0.42BRIEF-Psychemedics Corporation Q4 Earnings Per Share $0.42
www.reuters.com - March 8 at 4:34 PM
Psychemedics Corporation Announces Q4 and Year End ResultsPsychemedics Corporation Announces Q4 and Year End Results
finance.yahoo.com - March 8 at 10:39 AM
Psychemedics Corp. (PMD) Shares Bought by Moors & Cabot Inc.Psychemedics Corp. (PMD) Shares Bought by Moors & Cabot Inc.
www.americanbankingnews.com - March 5 at 3:44 PM
Psychemedics Corp. (PMD) is Tieton Capital Management LLCs 5th Largest PositionPsychemedics Corp. (PMD) is Tieton Capital Management LLC's 5th Largest Position
www.americanbankingnews.com - February 27 at 4:14 PM
Psychemedics (PMD) to Release Earnings on MondayPsychemedics (PMD) to Release Earnings on Monday
www.americanbankingnews.com - January 29 at 3:56 AM
6 Cheap Stocks With a High Dividend Yield6 Cheap Stocks With a High Dividend Yield
finance.yahoo.com - January 3 at 4:46 PM
ETFs with exposure to Psychemedics Corp. : November 27, 2017ETFs with exposure to Psychemedics Corp. : November 27, 2017
finance.yahoo.com - November 27 at 4:33 PM
Psychemedics Corporation (PMD) CEO Raymond C. Kubacki, Jr. Buys 1,000 SharesPsychemedics Corporation (PMD) CEO Raymond C. Kubacki, Jr. Buys 1,000 Shares
www.americanbankingnews.com - November 15 at 10:20 AM
Psychemedics Corp. : PMD-US: Dividend Analysis : November 06th, 2017 (record date) : By the numbers : November 6, 2017Psychemedics Corp. : PMD-US: Dividend Analysis : November 06th, 2017 (record date) : By the numbers : November 6, 2017
finance.yahoo.com - November 7 at 8:50 AM
Psychemedics Corporation (PMD) Rating Increased to Hold at BidaskClubPsychemedics Corporation (PMD) Rating Increased to Hold at BidaskClub
www.americanbankingnews.com - November 4 at 2:10 PM
ETFs with exposure to Psychemedics Corp. : October 30, 2017ETFs with exposure to Psychemedics Corp. : October 30, 2017
finance.yahoo.com - October 31 at 8:00 AM
Only 3 Days Left Before Psychemedics Corporation (PMD) Will Start Trading Ex-Dividend, Should You Buy?Only 3 Days Left Before Psychemedics Corporation (PMD) Will Start Trading Ex-Dividend, Should You Buy?
finance.yahoo.com - October 31 at 8:00 AM
Psychemedics Corp. :PMD-US: Earnings Analysis: Q3, 2017 By the Numbers : October 27, 2017Psychemedics Corp. :PMD-US: Earnings Analysis: Q3, 2017 By the Numbers : October 27, 2017
finance.yahoo.com - October 27 at 10:46 AM
Psychemedics Corporation (PMD) Plans Quarterly Dividend of $0.15Psychemedics Corporation (PMD) Plans Quarterly Dividend of $0.15
www.americanbankingnews.com - October 26 at 9:01 AM
Psychemedics Corporation Announces Q3 EarningsPsychemedics Corporation Announces Q3 Earnings
finance.yahoo.com - October 25 at 9:14 AM
Psychemedics Corporation (PMD) Announces  Earnings ResultsPsychemedics Corporation (PMD) Announces Earnings Results
www.americanbankingnews.com - October 24 at 8:28 PM
Psychemedics Corporation (PMD) Set to Announce Quarterly Earnings on TuesdayPsychemedics Corporation (PMD) Set to Announce Quarterly Earnings on Tuesday
www.americanbankingnews.com - October 17 at 5:58 AM
Does Psychemedics Corporation’s (PMD) PE Ratio Warrant A Buy?Does Psychemedics Corporation’s (PMD) PE Ratio Warrant A Buy?
finance.yahoo.com - October 3 at 10:52 AM
Psychemedics (PMD) Announces Addition of FDA-Cleared Benzodiazepines Hair TestPsychemedics (PMD) Announces Addition of FDA-Cleared Benzodiazepines Hair Test
www.streetinsider.com - September 27 at 11:00 PM
Psychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair TestPsychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair Test
finance.yahoo.com - September 27 at 11:00 PM
Insider Selling: Psychemedics Corporation (PMD) VP Sells 981 Shares of StockInsider Selling: Psychemedics Corporation (PMD) VP Sells 981 Shares of Stock
www.americanbankingnews.com - September 6 at 9:38 PM
Michael I. Schaffer Sells 4,400 Shares of Psychemedics Corporation (PMD) StockMichael I. Schaffer Sells 4,400 Shares of Psychemedics Corporation (PMD) Stock
www.americanbankingnews.com - September 6 at 9:16 PM
Michael I. Schaffer Sells 7,548 Shares of Psychemedics Corporation (PMD) StockMichael I. Schaffer Sells 7,548 Shares of Psychemedics Corporation (PMD) Stock
www.americanbankingnews.com - September 6 at 8:50 PM
ETFs with exposure to Psychemedics Corp. : August 21, 2017ETFs with exposure to Psychemedics Corp. : August 21, 2017
finance.yahoo.com - August 22 at 8:29 PM
Psychemedics Corporation Launches Synthetic Cannabinoids Hair TestPsychemedics Corporation Launches Synthetic Cannabinoids Hair Test
finance.yahoo.com - August 22 at 3:27 PM
Psychemedics Corporation - First Lab Approved For Hair Testing In IowaPsychemedics Corporation - First Lab Approved For Hair Testing In Iowa
finance.yahoo.com - August 17 at 6:57 AM
Psychemedics Corp. :PMD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 9, 2017Psychemedics Corp. :PMD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 9, 2017
finance.yahoo.com - August 10 at 6:58 AM
Psychemedics Corporation (NASDAQ:PMD) to Issue $0.15 Quarterly DividendPsychemedics Corporation (NASDAQ:PMD) to Issue $0.15 Quarterly Dividend
www.americanbankingnews.com - August 3 at 6:20 PM
Psychemedics Corporation Announces Q2 EarningsPsychemedics Corporation Announces Q2 Earnings
finance.yahoo.com - August 3 at 7:00 AM
Psychemedics posts 2Q profitPsychemedics posts 2Q profit
finance.yahoo.com - August 3 at 7:00 AM
Psychemedics Corporation (NASDAQ:PMD) Set to Announce Quarterly Earnings on MondayPsychemedics Corporation (NASDAQ:PMD) Set to Announce Quarterly Earnings on Monday
www.americanbankingnews.com - July 22 at 10:23 AM
Psychemedics posts 1Q profitPsychemedics posts 1Q profit
marketbeat.com - April 25 at 5:52 PM
Psychemedics Corp: Its Not A ShortPsychemedics Corp: It's Not A Short
seekingalpha.com - March 27 at 9:41 AM
The Royce Funds: An Analysis Of Particularly Interesting HoldingsThe Royce Funds: An Analysis Of Particularly Interesting Holdings
seekingalpha.com - March 25 at 8:44 AM
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline - April 3, 2017DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline - April 3, 2017
us.rd.yahoo.com - March 24 at 7:08 PM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline - April 3, 2017SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline - April 3, 2017
us.rd.yahoo.com - March 21 at 10:54 AM
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Psychemedics Corporation To Contact The Firm Before Lead Plaintiff DeadlineSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Psychemedics Corporation To Contact The Firm Before Lead Plaintiff Deadline
feeds.benzinga.com - March 15 at 9:33 PM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017
us.rd.yahoo.com - March 15 at 7:27 PM
DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Psychemedics Corporation To Contact The FirmDEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Psychemedics Corporation To Contact The Firm
us.rd.yahoo.com - March 11 at 2:04 AM
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017
us.rd.yahoo.com - March 11 at 2:04 AM
PSYCHEMEDICS CORP Files SEC form 10-K, Annual ReportPSYCHEMEDICS CORP Files SEC form 10-K, Annual Report
biz.yahoo.com - March 7 at 7:08 PM
PMD SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Psychemedics Corporation and a Lead Plaintiff Deadline of April 3, 2017PMD SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Psychemedics Corporation and a Lead Plaintiff Deadline of April 3, 2017
us.rd.yahoo.com - February 28 at 7:59 PM
SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the FirmSHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the Firm
us.rd.yahoo.com - February 28 at 7:59 PM
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Psychemedics Corporation (PMD) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action LawsuitSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Psychemedics Corporation (PMD) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
us.rd.yahoo.com - February 28 at 7:59 PM
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017
us.rd.yahoo.com - February 21 at 5:36 PM

SEC Filings

Psychemedics (NASDAQ:PMD) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Psychemedics (NASDAQ:PMD) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Psychemedics (NASDAQ PMD) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.